the positive announcements were released after 31st of December, and prior to that slew of good news, the mood around here was quite reserved.
I'm happy that the gross loss dropped by more than half.
Sales revenue has > tripled while COGS has > sextupled.
Liquidity is still ok but NOCF's shortfall has really jumped which means that they have to get cash flow +ve this year or get another injection.
R&D tax receipts and grant funding are much smaller compared to last year. It seems we are transitioning away from that business model. I approve.
CCE Price at posting:
4.0¢ Sentiment: Buy Disclosure: Held
